IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$15.58 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2022-11-01
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2022-09-30 was -$6.93M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2022-06-30 was -$16.41M, a 287.15% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2022-03-31 was $7.76M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2021-12-31 was -$1.68M, a 124.18% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for fiscal 2021 was -$5.64M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for fiscal 2020 was -$6.76M, a 279.36% decline from fiscal 2019.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for fiscal 2019 was $3.77M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), before reclassifications, net of tax for fiscal 2018 was -$6.11M, a 195.68% decline from fiscal 2017.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$6.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$23.34M derived: sum of 2 quarters · filed 2022-11-01 | -$15.58M 10-Q · filed 2022-11-01 | -$17.26M derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | -$16.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$8.65M 10-Q · filed 2022-08-02 | -$10.33M derived: sum of 3 quarters · filed 2022-08-02 | -$15.25M derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-03-31 | $7.76M 10-Q · filed 2022-05-04 | $6.08M derived: sum of 2 quarters · filed 2022-05-04 | $1.16M derived: sum of 3 quarters · filed 2022-11-01 | $9.93M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$6.60M derived: sum of 2 quarters · filed 2022-11-01 | $2.17M derived: sum of 3 quarters · filed 2022-11-01 | -$5.64M 10-K · filed 2022-02-16 |
| 2021-09-30 | -$4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $3.85M derived: sum of 2 quarters · filed 2022-11-01 | -$3.96M 10-Q · filed 2022-11-01 | $2.98M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $8.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $955.00K 10-Q · filed 2022-08-02 | $7.90M derived: sum of 3 quarters · filed 2022-08-02 | $2.47M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | -$7.82M 10-Q · filed 2022-05-04 | -$870.00K derived: sum of 2 quarters · filed 2022-05-04 | -$6.30M derived: sum of 3 quarters · filed 2022-05-04 | -$6.61M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.51M derived: sum of 2 quarters · filed 2022-02-16 | $1.20M derived: sum of 3 quarters · filed 2022-02-16 | -$6.76M 10-K · filed 2022-02-16 |
| 2020-09-30 | -$5.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$5.74M derived: sum of 2 quarters · filed 2021-11-02 | -$13.71M 10-Q · filed 2021-11-02 | -$11.96M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$313.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$8.28M 10-Q · filed 2021-07-30 | -$6.53M derived: sum of 3 quarters · filed 2021-07-30 | -$9.03M derived: sum of 4 quarters · filed 2021-07-30 |
| 2020-03-31 | -$7.96M 10-Q · filed 2021-05-04 | -$6.21M derived: sum of 2 quarters · filed 2021-05-04 | -$8.71M derived: sum of 3 quarters · filed 2021-05-04 | -$7.13M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$751.00K derived: sum of 2 quarters · filed 2021-02-12 | $832.00K derived: sum of 3 quarters · filed 2021-02-12 | $3.77M 10-K · filed 2021-02-12 |
| 2019-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$916.00K derived: sum of 2 quarters · filed 2020-10-29 | $2.02M 10-Q · filed 2020-10-29 | $3.56M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $4.52M 10-Q · filed 2020-07-31 | $6.06M derived: sum of 3 quarters · filed 2020-07-31 | $6.54M derived: sum of 4 quarters · filed 2020-07-31 |
| 2019-03-31 | $2.94M 10-Q · filed 2020-04-30 | $4.48M derived: sum of 2 quarters · filed 2020-04-30 | $4.96M derived: sum of 3 quarters · filed 2020-04-30 | -$3.85M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $2.02M derived: sum of 2 quarters · filed 2020-02-14 | -$6.79M derived: sum of 3 quarters · filed 2020-02-14 | -$6.11M 10-K · filed 2020-02-14 |
| 2018-09-30 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$8.33M derived: sum of 2 quarters · filed 2019-10-31 | -$7.65M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | -$8.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$8.13M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $679.00K 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $6.39M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |